APO Research
Talk to an analyst

APO RESEARCH · REPORT

Menopause Hormonal Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Menopause Hormonal Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchMenopause Hormonal Treatment Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Menopause Hormonal Treatment Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Menopause Hormonal Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Menopause Hormonal Treatment Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Menopause Hormonal Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Menopause Hormonal Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Menopause Hormonal Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Menopause Hormonal Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Menopause Hormonal Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Menopause Hormonal Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Menopause Hormonal Treatment include Teva Pharmaceutical Industries, Novartis, Novo Nordisk, Merck, Eli Lilly And Company, Pfizer, Bayer, AbbVie and Theramex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Menopause Hormonal Treatment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Menopause Hormonal Treatment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Menopause Hormonal Treatment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Menopause Hormonal Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Menopause Hormonal Treatment Segment by Company

Teva Pharmaceutical Industries

Novartis

Novo Nordisk

Merck

Eli Lilly And Company

Pfizer

Bayer

AbbVie

Theramex

Pure Encapsulations, Inc.

Emcure Pharmaceuticals

Cipla

Allergan

Menopause Hormonal Treatment Segment by Type

Table

Patch

Spray

Others

Menopause Hormonal Treatment Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Menopause Hormonal Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Menopause Hormonal Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Menopause Hormonal Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Menopause Hormonal Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Menopause Hormonal Treatment market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Menopause Hormonal Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Menopause Hormonal Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Menopause Hormonal Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Menopause Hormonal Treatment Industry Trends Table 2. Menopause Hormonal Treatment Industry Drivers Table 3. Menopause Hormonal Treatment Industry Opportunities and Challenges Table 4. Menopause Hormonal Treatment Industry Restraints Table 5. Global Menopause Hormonal Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Menopause Hormonal Treatment Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Menopause Hormonal Treatment Sales by Manufacturers (tons) & (2021-2026) Table 8. Global Menopause Hormonal Treatment Sales Market Share by Manufacturers Table 9. Global Menopause Hormonal Treatment Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global Menopause Hormonal Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Menopause Hormonal Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Menopause Hormonal Treatment Manufacturers, Product Type & Application Table 13. Global Menopause Hormonal Treatment Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Menopause Hormonal Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Table Table 17. Major Manufacturers of Patch Table 18. Major Manufacturers of Spray Table 19. Major Manufacturers of Others Table 20. Global Menopause Hormonal Treatment Sales by Type 2021 VS 2025 VS 2032 (tons) Table 21. Global Menopause Hormonal Treatment Sales by Type (2021-2026) & (tons) Table 22. Global Menopause Hormonal Treatment Sales by Type (2027-2032) & (tons) Table 23. Global Menopause Hormonal Treatment Sales Market Share by Type (2021-2026) Table 24. Global Menopause Hormonal Treatment Sales Market Share by Type (2027-2032) Table 25. Global Menopause Hormonal Treatment Revenue by Type 2021 VS 2025 VS 2032 (tons) Table 26. Global Menopause Hormonal Treatment Revenue by Type (2021-2026) & (tons) Table 27. Global Menopause Hormonal Treatment Revenue by Type (2027-2032) & (tons) Table 28. Global Menopause Hormonal Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Menopause Hormonal Treatment Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Retail Pharmacies Table 31. Major Manufacturers of Online Pharmacies Table 32. Major Manufacturers of Hospital Pharmacies Table 33. Global Menopause Hormonal Treatment Sales by Application 2021 VS 2025 VS 2032 (tons) Table 34. Global Menopause Hormonal Treatment Sales by Application (2021-2026) & (tons) Table 35. Global Menopause Hormonal Treatment Sales by Application (2027-2032) & (tons) Table 36. Global Menopause Hormonal Treatment Sales Market Share by Application (2021-2026) Table 37. Global Menopause Hormonal Treatment Sales Market Share by Application (2027-2032) Table 38. Global Menopause Hormonal Treatment Revenue by Application 2021 VS 2025 VS 2032 (tons) Table 39. Global Menopause Hormonal Treatment Revenue by Application (2021-2026) & (tons) Table 40. Global Menopause Hormonal Treatment Revenue by Application (2027-2032) & (tons) Table 41. Global Menopause Hormonal Treatment Revenue Market Share by Application (2021-2026) Table 42. Global Menopause Hormonal Treatment Revenue Market Share by Application (2027-2032) Table 43. Global Menopause Hormonal Treatment Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 44. Global Menopause Hormonal Treatment Sales by Region (2021-2026) & (tons) Table 45. Global Menopause Hormonal Treatment Sales Market Share by Region (2021-2026) Table 46. Global Menopause Hormonal Treatment Sales Forecasted by Region (2027-2032) & (tons) Table 47. Global Menopause Hormonal Treatment Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Menopause Hormonal Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 49. North America Menopause Hormonal Treatment Sales by Country (2021-2026) & (tons) Table 50. North America Menopause Hormonal Treatment Sales by Country (2027-2032) & (tons) Table 51. Europe Menopause Hormonal Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 52. Europe Menopause Hormonal Treatment Sales by Country (2021-2026) & (tons) Table 53. Europe Menopause Hormonal Treatment Sales by Country (2027-2032) & (tons) Table 54. Asia Pacific Menopause Hormonal Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 55. Asia Pacific Menopause Hormonal Treatment Sales by Country (2021-2026) & (tons) Table 56. Asia Pacific Menopause Hormonal Treatment Sales by Country (2027-2032) & (tons) Table 57. South America, Middle East and Africa Menopause Hormonal Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 58. South America, Middle East and Africa Menopause Hormonal Treatment Sales by Country (2021-2026) & (tons) Table 59. South America, Middle East and Africa Menopause Hormonal Treatment Sales by Country (2027-2032) & (tons) Table 60. Global Menopause Hormonal Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Menopause Hormonal Treatment Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Menopause Hormonal Treatment Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Menopause Hormonal Treatment Revenue Market Share by Region (2021-2026) Table 64. Global Menopause Hormonal Treatment Revenue Market Share by Region (2027-2032) Table 65. Teva Pharmaceutical Industries Company Information Table 66. Teva Pharmaceutical Industries Business Overview Table 67. Teva Pharmaceutical Industries Menopause Hormonal Treatment Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Teva Pharmaceutical Industries Menopause Hormonal Treatment Product Portfolio Table 69. Teva Pharmaceutical Industries Recent Development Table 70. Novartis Company Information Table 71. Novartis Business Overview Table 72. Novartis Menopause Hormonal Treatment Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Novartis Menopause Hormonal Treatment Product Portfolio Table 74. Novartis Recent Development Table 75. Novo Nordisk Company Information Table 76. Novo Nordisk Business Overview Table 77. Novo Nordisk Menopause Hormonal Treatment Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Novo Nordisk Menopause Hormonal Treatment Product Portfolio Table 79. Novo Nordisk Recent Development Table 80. Merck Company Information Table 81. Merck Business Overview Table 82. Merck Menopause Hormonal Treatment Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Merck Menopause Hormonal Treatment Product Portfolio Table 84. Merck Recent Development Table 85. Eli Lilly And Company Company Information Table 86. Eli Lilly And Company Business Overview Table 87. Eli Lilly And Company Menopause Hormonal Treatment Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Eli Lilly And Company Menopause Hormonal Treatment Product Portfolio Table 89. Eli Lilly And Company Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer Menopause Hormonal Treatment Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Pfizer Menopause Hormonal Treatment Product Portfolio Table 94. Pfizer Recent Development Table 95. Bayer Company Information Table 96. Bayer Business Overview Table 97. Bayer Menopause Hormonal Treatment Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Bayer Menopause Hormonal Treatment Product Portfolio Table 99. Bayer Recent Development Table 100. AbbVie Company Information Table 101. AbbVie Business Overview Table 102. AbbVie Menopause Hormonal Treatment Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. AbbVie Menopause Hormonal Treatment Product Portfolio Table 104. AbbVie Recent Development Table 105. Theramex Company Information Table 106. Theramex Business Overview Table 107. Theramex Menopause Hormonal Treatment Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Theramex Menopause Hormonal Treatment Product Portfolio Table 109. Theramex Recent Development Table 110. Pure Encapsulations, Inc. Company Information Table 111. Pure Encapsulations, Inc. Business Overview Table 112. Pure Encapsulations, Inc. Menopause Hormonal Treatment Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Pure Encapsulations, Inc. Menopause Hormonal Treatment Product Portfolio Table 114. Pure Encapsulations, Inc. Recent Development Table 115. Emcure Pharmaceuticals Company Information Table 116. Emcure Pharmaceuticals Business Overview Table 117. Emcure Pharmaceuticals Menopause Hormonal Treatment Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Emcure Pharmaceuticals Menopause Hormonal Treatment Product Portfolio Table 119. Emcure Pharmaceuticals Recent Development Table 120. Cipla Company Information Table 121. Cipla Business Overview Table 122. Cipla Menopause Hormonal Treatment Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Cipla Menopause Hormonal Treatment Product Portfolio Table 124. Cipla Recent Development Table 125. Allergan Company Information Table 126. Allergan Business Overview Table 127. Allergan Menopause Hormonal Treatment Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Allergan Menopause Hormonal Treatment Product Portfolio Table 129. Allergan Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Menopause Hormonal Treatment Distributors List Table 133. Menopause Hormonal Treatment Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Menopause Hormonal Treatment Product Image Figure 2. Global Menopause Hormonal Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Menopause Hormonal Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Menopause Hormonal Treatment Sales (2021-2032) & (tons) Figure 5. Global Menopause Hormonal Treatment Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 Menopause Hormonal Treatment Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Table Image Figure 9. Patch Image Figure 10. Spray Image Figure 11. Others Image Figure 12. Global Menopause Hormonal Treatment Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 13. Global Menopause Hormonal Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Menopause Hormonal Treatment Sales Market Share by Type (2021-2032) Figure 15. Global Menopause Hormonal Treatment Revenue by Type (2021 VS 2025 VS 2032) & (tons) Figure 16. Global Menopause Hormonal Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Menopause Hormonal Treatment Revenue Market Share by Type (2021-2032) Figure 18. Retail Pharmacies Image Figure 19. Online Pharmacies Image Figure 20. Hospital Pharmacies Image Figure 21. Global Menopause Hormonal Treatment Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 22. Global Menopause Hormonal Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Menopause Hormonal Treatment Sales Market Share by Application (2021-2032) Figure 24. Global Menopause Hormonal Treatment Revenue by Application (2021 VS 2025 VS 2032) & (tons) Figure 25. Global Menopause Hormonal Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Menopause Hormonal Treatment Revenue Market Share by Application (2021-2032) Figure 27. North America Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 28. North America Menopause Hormonal Treatment Sales Market Share by Country (2021-2032) Figure 29. U.S. Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 30. Canada Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 31. Mexico Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 32. Europe Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 33. Europe Menopause Hormonal Treatment Sales Market Share by Country (2021-2032) Figure 34. Germany Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 35. France Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 36. U.K. Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 37. Italy Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 38. Netherlands Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 39. Asia Pacific Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 40. Asia Pacific Menopause Hormonal Treatment Sales Market Share by Country (2021-2032) Figure 41. China Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 42. Japan Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 43. South Korea Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 44. Southeast Asia Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 45. India Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 46. Australia Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 47. South America, Middle East and Africa Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 48. South America, Middle East and Africa Menopause Hormonal Treatment Sales Market Share by Country (2021-2032) Figure 49. Brazil Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 50. South Africa Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 51. Saudi Arabia Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 52. Turkey Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 53. Argentina Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 54. UAE Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 55. Egypt Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 56. Chile Menopause Hormonal Treatment Sales and Growth Rate (2021-2032) & (tons) Figure 57. Global Menopause Hormonal Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Menopause Hormonal Treatment Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Menopause Hormonal Treatment Revenue (2021-2032) & (US$ Million) Figure 60. North America Menopause Hormonal Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Menopause Hormonal Treatment Revenue (2021-2032) & (US$ Million) Figure 62. Europe Menopause Hormonal Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Menopause Hormonal Treatment Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Menopause Hormonal Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Menopause Hormonal Treatment Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Menopause Hormonal Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Menopause Hormonal Treatment Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Menopause Hormonal Treatment Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Table
  • Patch
  • Spray
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Teva Pharmaceutical Industries
  • Novartis
  • Novo Nordisk
  • Merck
  • Eli Lilly And Company
  • Pfizer
  • Bayer
  • AbbVie
  • Theramex
  • Pure Encapsulations, Inc.
  • Emcure Pharmaceuticals
  • Cipla
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Menopause Hormonal Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Menopause Hormonal Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Menopause Hormonal Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Menopause Hormonal Treatment Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Menopause Hormonal Treatment Market Dynamics
  1. 2.1 Menopause Hormonal Treatment Industry Trends
  2. 2.2 Menopause Hormonal Treatment Industry Drivers
  3. 2.3 Menopause Hormonal Treatment Industry Opportunities and Challenges
  4. 2.4 Menopause Hormonal Treatment Industry Restraints
3 Menopause Hormonal Treatment Market by Manufacturers
  1. 3.1 Global Menopause Hormonal Treatment Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Menopause Hormonal Treatment Sales by Manufacturers (2021-2026)
  3. 3.3 Global Menopause Hormonal Treatment Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Menopause Hormonal Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Menopause Hormonal Treatment Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Menopause Hormonal Treatment Manufacturers, Product Type & Application
  7. 3.7 Global Menopause Hormonal Treatment Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Menopause Hormonal Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Menopause Hormonal Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Menopause Hormonal Treatment Tier 1, Tier 2, and Tier 3
4 Menopause Hormonal Treatment Market by Type
  1. 4.1 Menopause Hormonal Treatment Type Introduction
  2. 4.1.1 Table
  3. 4.1.2 Patch
  4. 4.1.3 Spray
  5. 4.1.4 Others
  6. 4.2 Global Menopause Hormonal Treatment Sales by Type
  7. 4.2.1 Global Menopause Hormonal Treatment Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Menopause Hormonal Treatment Sales by Type (2021-2032)
  9. 4.2.3 Global Menopause Hormonal Treatment Sales Market Share by Type (2021-2032)
  10. 4.3 Global Menopause Hormonal Treatment Revenue by Type
  11. 4.3.1 Global Menopause Hormonal Treatment Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Menopause Hormonal Treatment Revenue by Type (2021-2032)
  13. 4.3.3 Global Menopause Hormonal Treatment Revenue Market Share by Type (2021-2032)
5 Menopause Hormonal Treatment Market by Application
  1. 5.1 Menopause Hormonal Treatment Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Menopause Hormonal Treatment Sales by Application
  6. 5.2.1 Global Menopause Hormonal Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Menopause Hormonal Treatment Sales by Application (2021-2032)
  8. 5.2.3 Global Menopause Hormonal Treatment Sales Market Share by Application (2021-2032)
  9. 5.3 Global Menopause Hormonal Treatment Revenue by Application
  10. 5.3.1 Global Menopause Hormonal Treatment Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Menopause Hormonal Treatment Revenue by Application (2021-2032)
  12. 5.3.3 Global Menopause Hormonal Treatment Revenue Market Share by Application (2021-2032)
6 Global Menopause Hormonal Treatment Sales by Region
  1. 6.1 Global Menopause Hormonal Treatment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Menopause Hormonal Treatment Sales by Region (2021-2032)
  3. 6.2.1 Global Menopause Hormonal Treatment Sales by Region (2021-2026)
  4. 6.2.2 Global Menopause Hormonal Treatment Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Menopause Hormonal Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Menopause Hormonal Treatment Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Menopause Hormonal Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Menopause Hormonal Treatment Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Menopause Hormonal Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Menopause Hormonal Treatment Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Menopause Hormonal Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Menopause Hormonal Treatment Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Menopause Hormonal Treatment Revenue by Region
  1. 7.1 Global Menopause Hormonal Treatment Revenue by Region
  2. 7.1.1 Global Menopause Hormonal Treatment Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Menopause Hormonal Treatment Revenue by Region (2021-2026)
  4. 7.1.3 Global Menopause Hormonal Treatment Revenue by Region (2027-2032)
  5. 7.1.4 Global Menopause Hormonal Treatment Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Menopause Hormonal Treatment Revenue (2021-2032)
  8. 7.2.2 North America Menopause Hormonal Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Menopause Hormonal Treatment Revenue (2021-2032)
  11. 7.3.2 Europe Menopause Hormonal Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Menopause Hormonal Treatment Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Menopause Hormonal Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Menopause Hormonal Treatment Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Menopause Hormonal Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries
  2. 8.1.1 Teva Pharmaceutical Industries Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Menopause Hormonal Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Menopause Hormonal Treatment Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Menopause Hormonal Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Menopause Hormonal Treatment Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Novo Nordisk
  14. 8.3.1 Novo Nordisk Company Information
  15. 8.3.2 Novo Nordisk Business Overview
  16. 8.3.3 Novo Nordisk Menopause Hormonal Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novo Nordisk Menopause Hormonal Treatment Product Portfolio
  18. 8.3.5 Novo Nordisk Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Menopause Hormonal Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Menopause Hormonal Treatment Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Eli Lilly And Company
  26. 8.5.1 Eli Lilly And Company Company Information
  27. 8.5.2 Eli Lilly And Company Business Overview
  28. 8.5.3 Eli Lilly And Company Menopause Hormonal Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eli Lilly And Company Menopause Hormonal Treatment Product Portfolio
  30. 8.5.5 Eli Lilly And Company Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Menopause Hormonal Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Menopause Hormonal Treatment Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Menopause Hormonal Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Menopause Hormonal Treatment Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 AbbVie
  44. 8.8.1 AbbVie Company Information
  45. 8.8.2 AbbVie Business Overview
  46. 8.8.3 AbbVie Menopause Hormonal Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AbbVie Menopause Hormonal Treatment Product Portfolio
  48. 8.8.5 AbbVie Recent Developments
  49. 8.9 Theramex
  50. 8.9.1 Theramex Company Information
  51. 8.9.2 Theramex Business Overview
  52. 8.9.3 Theramex Menopause Hormonal Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Theramex Menopause Hormonal Treatment Product Portfolio
  54. 8.9.5 Theramex Recent Developments
  55. 8.10 Pure Encapsulations, Inc.
  56. 8.10.1 Pure Encapsulations, Inc. Company Information
  57. 8.10.2 Pure Encapsulations, Inc. Business Overview
  58. 8.10.3 Pure Encapsulations, Inc. Menopause Hormonal Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pure Encapsulations, Inc. Menopause Hormonal Treatment Product Portfolio
  60. 8.10.5 Pure Encapsulations, Inc. Recent Developments
  61. 8.11 Emcure Pharmaceuticals
  62. 8.11.1 Emcure Pharmaceuticals Company Information
  63. 8.11.2 Emcure Pharmaceuticals Business Overview
  64. 8.11.3 Emcure Pharmaceuticals Menopause Hormonal Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Emcure Pharmaceuticals Menopause Hormonal Treatment Product Portfolio
  66. 8.11.5 Emcure Pharmaceuticals Recent Developments
  67. 8.12 Cipla
  68. 8.12.1 Cipla Company Information
  69. 8.12.2 Cipla Business Overview
  70. 8.12.3 Cipla Menopause Hormonal Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cipla Menopause Hormonal Treatment Product Portfolio
  72. 8.12.5 Cipla Recent Developments
  73. 8.13 Allergan
  74. 8.13.1 Allergan Company Information
  75. 8.13.2 Allergan Business Overview
  76. 8.13.3 Allergan Menopause Hormonal Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Allergan Menopause Hormonal Treatment Product Portfolio
  78. 8.13.5 Allergan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Menopause Hormonal Treatment Value Chain Analysis
  2. 9.1.1 Menopause Hormonal Treatment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Menopause Hormonal Treatment Production Mode & Process
  6. 9.2 Menopause Hormonal Treatment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Menopause Hormonal Treatment Distributors
  9. 9.2.3 Menopause Hormonal Treatment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst